Literature DB >> 12663497

Transcriptional upregulation of the insulin-like growth factor binding protein IGFBP-3 by sodium butyrate increases IGF-independent apoptosis in human colonic adenoma-derived epithelial cells.

T J Collard1, M Guy, A J Butt, C M Perks, J M P Holly, C Paraskeva, A C Williams.   

Abstract

Sodium butyrate (NaBt) and the pro-apoptotic IGFBP-3 protein, expressed at the top of the normal colonic crypt, have both been implicated in the regulation of apoptosis in colonic epithelial cells. Recent studies in human breast and hepatic cell lines have shown that NaBt can transcriptionally upregulate IGFBP-3 expression. However, the role of butyrate in the regulation of IGFBP-3 expression in the colon is less clear, with reports of both up- and downregulation of the IGFBP-3 protein in colorectal cancer cell lines. In this study we have shown that the level of IGFBP-3 protein expression in colonic epithelial cells correlates with the p53 status of the cells; wildtype p53 cells secrete higher levels of IGFBP3 protein than mutant p53 cell lines. Data presented shows that, when treated with a dose of NaBt that induced significant apoptosis (4 mM for 48 h), there was an upregulation of IGFBP-3 protein in both wildtype and mutant p53 expressing cell lines. The NaBt-induced increase in secreted IGFBP-3 protein was associated with transcriptional upregulation of the IGFBP-3 gene. Using a transfected derivative of the S/RG/C2 adenoma-derived cell line, which stably expressed exogenous IGFBP-3 protein at levels equivalent to that secreted by the 4 mM NaBt-treated parental line (1-3 ng/10(6) cells), we have shown a >2-fold increase in the sensitivity of the cells to NaBt-induced apoptosis when compared with the vector control and parental cell lines. Furthermore, inhibition of the secreted IGFBP-3 protein, by addition of neutralizing antibodies, resulted in a significant decrease in NaBt-induced apoptosis. These data suggest that IGFBP-3 may act as a positive regulator of NaBt-induced apoptosis in colonic epithelial cells, and represents a potentially important mechanism whereby the sensitivity of colonic epithelial cells to NaBt-induced apoptosis can be increased.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12663497     DOI: 10.1093/carcin/24.3.393

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  17 in total

1.  Low expression of IGFBP-3 predicts poor prognosis in patients with esophageal squamous cell carcinoma.

Authors:  Lei Zhao; Li-Ru He; Rui Zhang; Mu-Yan Cai; Yi-Ji Liao; Dong Qian; Mian Xi; Yi-Xin Zeng; Dan Xie; Meng-Zhong Liu
Journal:  Med Oncol       Date:  2011-12-14       Impact factor: 3.064

Review 2.  The insulin-like growth factor system and colorectal cancer: clinical and experimental evidence.

Authors:  M Davies; S Gupta; G Goldspink; M Winslet
Journal:  Int J Colorectal Dis       Date:  2005-06-16       Impact factor: 2.571

3.  Histone deacetylase inhibitors enhance the apoptotic activity of insulin-like growth factor binding protein-3 by blocking PKC-induced IGFBP-3 degradation.

Authors:  Seung Hyun Oh; Young Mi Whang; Hye-Young Min; Seung Ho Han; Ju-Hee Kang; Ki-Hoon Song; Bonnie S Glisson; Yeul Hong Kim; Ho-Young Lee
Journal:  Int J Cancer       Date:  2012-03-28       Impact factor: 7.396

4.  IGFBP-3 Gene Methylation in Primary Tumor Predicts Recurrence of Stage II Colorectal Cancers.

Authors:  Tao Fu; Emmanouil P Pappou; Angela A Guzzetta; Marilia de Freitas Calmon; Lifeng Sun; Alexander Herrera; Fan Li; Christopher L Wolfgang; Stephen B Baylin; Christine A Iacobuzio-Donahue; Weidong Tong; Nita Ahuja
Journal:  Ann Surg       Date:  2016-02       Impact factor: 12.969

Review 5.  The role of the insulin-like growth factor system in colorectal cancer: review of current knowledge.

Authors:  Rajaraman Durai; Wenxuan Yang; Sharmila Gupta; Alexander M Seifalian; Marc C Winslet
Journal:  Int J Colorectal Dis       Date:  2005-01-14       Impact factor: 2.571

6.  Novel actions of IGFBP-3 on intracellular signaling pathways of insulin-secreting cells.

Authors:  Xiaoyan Chen; Robert J Ferry
Journal:  Growth Horm IGF Res       Date:  2005-11-04       Impact factor: 2.372

7.  Epigenetic regulation of insulin-like growth factor binding protein-3 (IGFBP-3) in cancer.

Authors:  Claire M Perks; Jeff Mp Holly
Journal:  J Cell Commun Signal       Date:  2015-04-29       Impact factor: 5.782

8.  IGFBP-3 sensitizes prostate cancer cells to interferon-gamma-induced apoptosis.

Authors:  Peng Fang; Vivian Hwa; Brian M Little; Ron G Rosenfeld
Journal:  Growth Horm IGF Res       Date:  2007-08-24       Impact factor: 2.372

9.  Apoptotic sensitivity of colon cancer cells to histone deacetylase inhibitors is mediated by an Sp1/Sp3-activated transcriptional program involving immediate-early gene induction.

Authors:  Andrew J Wilson; Anderly C Chueh; Lars Tögel; Georgia A Corner; Naseem Ahmed; Sanjay Goel; Do-Sun Byun; Shannon Nasser; Michele A Houston; Minaxi Jhawer; Helena J M Smartt; Lucas B Murray; Courtney Nicholas; Barbara G Heerdt; Diego Arango; Leonard H Augenlicht; John M Mariadason
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

Review 10.  IGF binding proteins (IGFBPs) and regulation of breast cancer biology.

Authors:  Claire M Perks; Jeff M P Holly
Journal:  J Mammary Gland Biol Neoplasia       Date:  2008-11-25       Impact factor: 2.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.